[Diagnosis and treatment of infectious pharyngeal inflammation].
Symptoms of viral and/or streptococcal infectious pharyngitis are of interest in the context of different therapeutic strategies. This study involved 3 family medicine clinics, one emergency service department, and 694 patients. Streptococcal pharyngitis occurred in 24% of the adult patients and in 29% of all the patients. The remaining ones had acute viral pharyngitis or a mixed viral/bacterial infection. Medicamentous therapy given to 98% of the patients included local antibiotics (42%), systemic antibacterial monotherapy (12%), and combined antibiotic therapy (44%). Lysozime-containing preparations (larypront, dequalar, etc.) recommended for pathogenetic therapy had the active ingredient in the form of a dequalinium complex to deliver lysozime to pharyngeal mucosa. The frequency of streptococcal infection in patients with secondary sore throat receiving the combined treatment was twice lower (12%) than in the general group. The strategy of therapy was the same as in primary sore throat.
Cooper
A J
AJ
Scott
M F
MF
Rollnick
S A
SA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D010612:Pharyngitis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D013290:Streptococcal Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D013291:Streptococcus / Q000302:isolation & purification; D016896:Treatment Outcome; D055815:Young Adult
D000900:Anti-Bacterial Agents